Suicidality and Antidepressant Drugs

Antidepressants augmented the risk compared with the placebo of suicidal reflexion and of behaviour (suicidality) at the children, the teenagers and the young adults in short-term studies of important depressive riot (MDD) and other psychiatric riot. Somebody by considering the use of Sinequan or whoever of other antidepressant at a child, a teenager, or a young adult owes balance this risk with the clinical need. Short-term studies did not show increase in risk of suicidality with antidepressants compared with the placebo in the adults beyond age 24; he had has there the reduction of risk with antidepressants compared with the placebo in the old adults 65 and older.

Depression and some of other psychiatric riot are linked to increase in the risk of suicide. The patients of all ages which are begun on the therapy of antidepressant should be controlled properly and noticed nearly for fact to damage private hospital, suicidality, or unusual changes in behaviour. They should recommend to families and caregivers of the need for close observation and communication with the prescriber. Sinequan is not approved for use in paediatrics patients. (See Warnings: Risk of Suicide and to Damage Private hospital, Precautions: Information for The patients and Precautions: Use of Paediatrics)